The American Heart Association (AHA) has shared new recommendations for providing emergency cardiovascular care, including CPR, to patients with known or suspected COVID-19.

Key chemotherapy treatments are known to have a negative impact on cardiovascular health, even leading to heart failure (HF) in some patients.

The Montreal Heart Institute has launched a new clinical trial aimed at improving care for patients who have been diagnosed with COVID-19.

Americans are dying from cardiovascular disease (CVD) caused or exacerbated by hypertension at alarmingly higher rates than in years past.

Cardiovascular care professionals must consider the concerns and views of healthcare workers, members of hospital/health system leadership and, not least, patients—whether the latter are infected with COVID-19 or not.

The presence of mental stress is a key predictor of when MI patients may have a repeat MI or die from heart disease, according to new research highlighted by the American College of Cardiology.

Following data supporting their use for heart failure and type 2 diabetes, will sodium-glucose cotransporter 2 inhibitors find a spot in the heart failure armamentarium?